Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma receptor (IFNgR) signaling pathway is critical for susceptibility of glioblastoma tumors to killing by CAR T-cell immunotherapy. ...
Jun 10, 2022
0
52
[Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular ...
Apr 19, 2022
0
51
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
Jul 21, 2013
0
0
(Medical Xpress) -- Yale University researchers have identified four unique host defense proteins among thousands that seem to play a crucial role in mobilizing the immune system's response to bacterial infections, they report ...
May 6, 2011
0
0
COVID-19 is anticipated to keep causing regular outbreak waves for the foreseeable future. The recent COVID-19 waves have caused fewer hospitalizations and deaths than the initial ones, which is largely due to the immunity ...
Aug 8, 2022
0
38
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment ...
Feb 15, 2016
0
247
The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there ...
Nov 18, 2015
0
23
A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the ...
May 13, 2015
0
5
(HealthDay)—For patients with chronic hepatitis C virus genotype 1 (HCV GT-1) infection who are ineligible for interferon therapy, and who relapsed after sofosbuvir and ribavirin treatment, sofosbuvir plus ledipasvir is ...
Nov 4, 2014
0
1
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. ...
Mar 20, 2014
0
0
